Maternal and Fetal Alternative Complement Pathway Activation in Early Severe Preeclampsia

American Journal of Reproductive Immunology

Volumn 71, Issue 1, 2014, Pages 55-60

  Hoffman, M Camille ^a   Rumer, Kristen K ^a   Kramer, Anita ^a   Lynch, Anne M ^a   Winn, Virginia D ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Activation fragment Bb; Alternative complement pathway; Severe Preeclampsia

Indexed keywords

COMPLEMENT; COMPLEMENT PATHWAY ACTIVATION FRAGMENT BB; UNCLASSIFIED DRUG; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; PLASMA PROTEIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; MATERNAL AGE; MATERNAL PLASMA; PARITY; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UMBILICAL CORD BLOOD; DISEASE COURSE; FETUS BLOOD; IMMUNOLOGY; METABOLISM; MOTHER; PREGNANCY; YOUNG ADULT;

ADULT; BLOOD PROTEINS; COMPLEMENT FACTOR B; COMPLEMENT PATHWAY, ALTERNATIVE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FETAL BLOOD; FETUS; HUMANS; MOTHERS; PRE-ECLAMPSIA; PREGNANCY; YOUNG ADULT;

EID: 84890150731     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12162     Document Type: Article

References (21)

1. McMaster MT, Zhou Y, Fisher SJ: Abnormal placentation and the syndrome of preeclampsia. Semin Nephrol 2004; 24:540-547.
2. Dekker G, Robillard PY: Pre-eclampsia: is the immune maladaptation hypothesis still standing? An epidemiological update J Reprod Immunol 2007; 76:8-16.
3. Sibai B, Dekker G, Kupferminc M: Pre-eclampsia. Lancet 2005; 365:785-799.
4. Redman CW, Sargent IL: Placental stress and pre-eclampsia: a revised view. Placenta 2009; 30(Suppl A):S38-S42.
5. Walport MJ: Complement. First of two parts. N Engl J Med 2001; 344:1058-1066.
6. Salmon JE, Girardi G, Holers VM. Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis. Ann Rheum Dis 2002; 61(Suppl 2): ii46-ii50.
7. Holers VM, Girardi G, Mo L, Guthridge JM, Molina H, Pierangeli SS, Espinola R, Xiaowei LE, Mao D, Vialpando CG, Salmon JE: Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002; 195:211-220.
8. Caucheteux SM, Kanellopoulos-Langevin C, Ojcius DM: At the innate frontiers between mother and fetus: linking abortion with complement activation. Immunity 2003; 18:169-172.
9. Mellembakken JR, Hogasen K, Mollnes TE, Hack CE, Abyholm T, Videm V: Increased systemic activation of neutrophils but not complement in preeclampsia. Obstet Gynecol 2001; 97:371-374.
10. Haeger M, Unander M, Bengtsson A: Complement activation in relation to development of preeclampsia. Obstet Gynecol 1991; 78:46-49.
11. Lynch AM, Murphy JR, Byers T, Gibbs RS, Neville MC, Giclas PC, Salmon JE, Holers VM: Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. Am J Obstet Gynecol 2008; 198:385. e1-9.
12. Pavlov IY, De Forest N, Delgado JC: Specificity of EIA immunoassay for complement factor Bb testing. Clin Lab 2011; 57:225-228.
13. Kolb WP, Morrow PR, Tamerius JD: Ba and Bb fragments of factor B activation: fragment production, biological activities, neoepitope expression and quantitation in clinical samples. Complement Inflamm 1989; 6:175-204.
14. Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM: HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at < or=28.0 weeks' gestation. Am J Obstet Gynecol 2000; 183:1475-1479.
15. Sibai BM, Barton JR: Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol 2007; 196:514. e1-9.
16. Haddad B, Sibai BM: Expectant management in pregnancies with severe pre-eclampsia. Semin Perinatol 2009; 33:143-151.
17. Newton ER, Prihoda TJ, Gibbs RS: Logistic regression analysis of risk factors for intra-amniotic infection. Obstet Gynecol 1989; 73:571-575.
18. Vaisbuch E, Romero R, Erez O, Mazaki-Tovi S, Kusanovic JP, Soto E, Dong Z, Chaiworapongsa T, Kim SK, Ogge G, Pacora P, Yeo L, Hassan SS: Activation of the alternative pathway of complement is a feature of pre-term parturition but not of spontaneous labor at term. Am J Reprod Immunol 2010; 63:318-330.
19. Derzsy Z, Prohaszka Z, Rigo J Jr, Fust G, Molvarec A: Activation of the complement system in normal pregnancy and preeclampsia. Mol Immunol 2011; 47:1500-1506.
20. Lynch AM, Gibbs RS, Murphy JR, Byers T, Neville MC, Giclas PC, Salmon JE, Van Hecke TM, Holers VM: Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. Am J Obstet Gynecol 2008; 199:354. e1-8.
21. Lynch AM, Murphy JR, Gibbs RS, Levine RJ, Giclas PC, Salmon JE, Holers VM: The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia. BJOG 2010; 117:456-462.